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A CLINICAL STUDY ON MESENTERIC VASCULAR 
OCCLUSIVE DISEASE :
Abstract:
Acute mesenteric ischemia is a condition that  is very difficult 
to diagnose and is thought of atlast juncture  with  most cases 
resulting in increased morbidity & mortality. Smokers and   known 
peripheral vascular  occlusive  disease patients  with symptoms of  
post prandialangina  are mandatory  to screen  with  colour doppler 
and Further confirmed by CT Angiogram for early diagnosis of 
mesenteric  ischemia. Due to obligue origin of superior  
mesenteric (SMA) artric  from visceral  aortic segment, SMA is most 
common mesenteric Vessel  to undergo  disease involvement.  
Hence  high index  of suspicion  is necessary for earlier  diagnosis  
and decreasing  morbidity and mortality.
Keyword :
Mesenteric ischemia, superior mesenteric artery thrombosis, 
colour doppler, CT Angiogram.
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ABBREVATIONS: 
AMI – Acute Mesenteric Ischemia 
CMI – Chronic Mesenteric Ischemia 
CI – Colonic Ischemia 
SMA – Superior Mesenteric Artery 
IMA – Inferior Mesenteric Artery 
SMV – Superior Mesenteric Vein 
IMV – Inferior Mesenteric Vein 
MVT – Mesenteric Venous Thrombosis
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INTRODUCTION: 
Acute Mesenteric Ischaemia (AMI) is a condition that is very difficult to 
diagnose and is thought of at the last juncture with most cases resulting in 
increased morbidity and mortality. Though conditions like volvulus, 
intussception, hernias that are strangulated and intestinal obstruction in later 
stages can result in gangrene of the intestine, their number is minimal when 
compared to acute mesenteric ischemia as an inciting event. 
 The clinical presentation and the patients risk factor profile gives an idea 
of the underlying etiological process with severe abdominal pain out of 
proportion to the signs. . Patients with history of recent MI, atrial fibrillation, 
congestive heart failure,or peripheral arterial emboli are at a risk for an Superior 
Mesenteric Artery embolus. 
  Because of its oblique origin from the visceral aortic segment, SMA is 
the most common mesenteric vessel to undergo embolism. Thromboemboli tend 
to lodge in the proximal SMA, just beyond the few jejunal branches as the 
Superior Mesenteric Artery tapers. A minority (15%) may lodge at the SMA 
origin, but 50% lodge distal to the middle colic artery, creating a classic pattern 
of ischemia that spares the first portion of small intestine and the ascending 
colon. Atheroembolic emboli, in contrast, tend to be smaller and therefore lodge 
in the more distal mesenteric circulation. As a result, these emboli are likely to 
affect bowel perfusion less often and in more localised areas. Mesenteric venous 
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thrombosis (MVT) is rare and accounts for 5 to 15% of all acute mesenteric 
ischaemia.  
Severe abdominal pain is the most common presentation of AMI. This 
can be sudden and dramatic in a previously well and asymptomatic patient 
(embolism), recurrent abdominal pain precipitating into unrelenting 
pain(thrombosis) or vague colicky abdominal pain which is progressive over 1 
to 2 weeks (MVT). Copious vomiting ,diarrhoea and urge to defeacate are the 
associated symptoms. In the unconscious patient, abdominal distension, 
gastrointestinal bleeding,occult sepsis (leucocytosis or fever) and worsening 
metabolic acidosis may be the  presenting features. 
 Physical examination may reveal non specific abdominal distension and 
non specific abdominal pain. Peritonism or blood in the stool or vomitus 
indicates advanced gastrointestinal ischaemia with likely intestinal gangrene 
and is mostly a recognised late feature. Mortality for AMI remains high, and 
patients requiring extensive gut resection are unlikely to survive. Patients 
surviving intestinal resection may develop short gut syndrome. The prognosis 
dramatically improves if revascularisation can be achieved prior to intestinal 
infarction. 
The key to the successful management depends on the surgeon’s ability 
to suspect the diagnosis, pursue appropriate investigations and institute 
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aggressive treatment. The mortality remains high due to difficulty and delay in 
the diagnosis . Delay in diagnosis contributes directly to ischaemic damage.  
With the background of four to eight cases of bowel gangrene presenting 
with acute intestinal obstruction in a month in our hospital with unknown 
etiologies, a study to identify the cause and ways to improve the morbidity and 
mortality of the diseased population remained vital. 
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• AIMS AND OBJECTIVES: 
    
a. to study the factors which lead on to mesentric vascular catastrophe. 
 
 
b. to diagnose the disease early in patients with high risk factors before the 
onset of  bowel ischemia by various modalities. 
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MATERIALS AND METHODS: 
 
Materials: 
            Study data collection formats 
Paper  
Pencil 
 
Personnel:  
            Radiologist 
Surgeons of all Units in Department of General Surgery 
Nursing and Theatre staff 
 
Study population: 
         All the patients admitted in Coimbatore Medical College Hospital with the 
following criteria: 
 Chronic smokers complaining of chronic abdominal pain especially post-
prandial pain, food fear and weight loss not diagnosed by other 
modalities. 
 Chronic abdominal pain with known peripheral vascular disease ( 
atherosclerosis ) 
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 Women taking contraceptive pills with chronic abdominal pain and 
hypercoagulable states. 
 Patients with coronary heart disease (IHD) with or without bloody 
diarrhoea. 
 Aged greater than sixty years with atherosclerotic changes. 
 Patients presenting with acute intestinal obstruction due to gangrenous 
bowel. 
 Patients admitted with thromboembolic manifestations. 
Pregnant women and patients presenting with intestinal obstruction due to mass 
lesion or intraluminal obstruction were excluded from the study. 
A total of 57 patients were part of the study over a period of one year.  
Blood samples were collected from all the patients with the above criteria 
and complete hemogram, blood sugar urea, serum creatinine, serum 
electrolytes, serum lactate, lipid profile, PT INR were estimated. Chest x ray 
and ECG was taken. 
Patients who were included in the study were subjected to Doppler 
ultrasound and a further confirmatory CT angiogram was done when mandatory 
for eluding a diagnosis of acute mesenteric vascular occlusion. Intra operative 
findings were noted for all the cases which were operated were taken and 
biopsy of the suspected vessel that was occluded was taken. 
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           Further anticoagulant therapy using heparin was started for cases post 
operatively for patients having evidence of thrombosis intra operatively and 
patients with proven mesenteric vascular occlusion. Thrombectomy was done 
for patients intra operatively when the need calls.  
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• STUDY PROTOCOL: 
 
1. Disease diagnosed in high risk population could be managed 
conservatively by life style modification like cessation of smoking, 
BPcontrol,lowering HbA1C<7%,statins, antiplatelet therapy,angioplasty 
with or without stenting. 
 
2. Disease diagnosed in acute episodes could be managed by operative 
interventions like thrombectomy or embolectomy with resection and 
anastomosis of bowel with postoperative statins and antiplatelet therapy. 
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REVIEW OF LITERATURE: 
 
Hypoxia of the small bowel and colon invariably lead to gastrointestinal 
ischemia and infarction (Tables 1 and 2). Ischemic bowel disease occurs as a 
result of insufficient vascular supply to the gut in acute or chronic episodes thus 
resulting in chronic small bowel and colonic ischemia (CI) and infarction. 
Vascular compromise of the gut is a complex multifaceted condition that 
depends on the (1) systemic circulatory state (2) extent of anatomic or 
functional compromise of the vasculature, (3) number of vessels affected and 
their calibre  (4) vascular bed response to diminished perfusion (5) extent of 
collateral circulation, (6) time duration of ischemic insult, and (7)  requirements 
of the involved bowel segment.
1–12
 Patients who have intestinal ischemic 
disorders mostly present with pain abdomen and other nonspecific symptoms 
(nausea, diarrhoea, bloating and vomiting). Mesenteric ischemia is thought of as 
a final possibility after ruling out conditions like cholelithiasis, peptic ulcer 
disease, bowel obstruction, appendicitis, diverticulitis, and gastroenteritis. 
Accordingly, a high index of radiologic and clinical suspicion is required to 
diagnose ischemia and infarction of the gut.
1–12
 Gastrointestinal tract ischemia 
can affect bowel viability with potentially catastrophic consequences, including 
intestinal necrosis and gangrene. Radiologic imaging modalities provide earlier 
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and more precise diagnosis and hence result in decreased morbidity and 
mortality of this life threatening condition
.1–12
 
EPIDEMIOLOGY: 
Vascular compromise of the gut is responsible for approximately 0.2% of 
hospital admissions and 1% of patients admitted with pain abdomen. The 
diagnosis of this disorder is on the increase for several reasons. Mesenteric 
Ischemia (MI) and infarction occur in old age and they mostly have an 
associated comorbid systemic dysfunction or cardiovascular disease . The 
population is aging, and the number of cases of Mesenteric Ischemia is expected 
to increase dramatically as the ‘‘Baby Boom’’ generation comes of age. Other 
factors include improved diagnostic techniques,heightened awareness of this 
diagnosis, and the efficacy of intensive care units to salvage critically ill 
patients.
13–28
 
The causes of Mesenteric Ischemia are protean (Boxes 1–3). 
Bowel ischemia most commonly occurs within the sixth and seventh decades of 
life. The age of onset depends on patient gender and the etiology of the 
ischemia. Primary mesenteric venous thrombosis (MVT) and non occlusive 
mesenteric ischemia (NOMI) present at the ages of 66.5 and 63 years, 
respectively
.8
 Superior mesenteric artery (SMA) occlusion and non primary 
MVT present nearly a decade later, at the ages of 77.5 and 74 years, 
respectively.8 Chronic mesenteric ischemia (CMI) presents in younger patients 
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than those with acute mesenteric ischemia (AMI), with a female prevalence as 
high as 4:1. This is in contrast to the overwhelming prevalence of men with 
peripheral vascular and aneurysmal disease. Generally, women present with 
ischemia at an earlier age than their male counterparts, which may contribute to 
the overall earlier age of onset of CMI.
13–28
 
Prompt diagnosis of MI is facilitated by recognizing the various risk factors and 
comorbidities. Although there is significant overlap among the risk factors for 
the various vascular disorders of the intestines, certain etiology-specific risk 
factors have been described. 
Acute Mesenteric Ischemia has been associated with recent myocardial 
infarction, intra-abdominal malignancies, and emboli to the extremities.
22
  There 
is a greater than 50% association between CMI and coronary artery disease, 
peripheral vascular disease, hypertension, and smoking.  
Tobacco use is strongly associated with gut ischemia, with some 70% to 90% of 
patients admitting to significant use
.6–9
 
 
INTESTINALVASCULAR ANATOMY 
Knowledge of mesenteric vascular anatomy and physiology is key to an 
appreciation of the causes and consequences of intestinal ischemia and 
infarction. The anatomy of the mesenteric circulation is complicated by the 
almost endless variations of blood supply to the gut. 
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Celiac Axis 
Abdominal aorta has celiac artery as its largest branch, and it supplies the 
embryologic foregut. It leaves the abdominal aorta at an angle of 90 
0  
at the 
level of the T12 or L1 vertebral body. After coursing ventrally and inferiorly 1 
to 2 cm, the celiac artery branches into the splenic, common hepatic and left 
gastric arteries in most of the population. In 25%, there is a true trifurcation of 
these vessels, and in 1%, there is a common origin of the celiac and superior 
mesenteric branches—the celiacomesenteric trunk.16 
 
The common hepatic artery gives rise to the gastroduodenal artery, which then 
becomes the right gastroepiploic artery and posterior and anterior superior 
pancreaticoduodenal arteries. 
Typically, the left gastroepiploic artery arises from the splenic artery, 
which joins the right gastroepiploic artery.
16
 
Superior Mesenteric Artery 
The SMA (Fig. 2) is a large-caliber structure with a narrow takeoff from the 
aorta, making it the most susceptible of the major mesenteric vessels to embolic 
phenomena. It supplies the entire embryologic midgut and is the second largest 
intra-abdominal branch of the aorta. 
 There is great potential for distal anastomoses as there are more SMA 
branches to the distal small bowel than to the proximal portions.
12,26
 The SMA 
originates 1 cm below the level of the celiac artery  at the level of L1, and 
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course downwards toward the right and terminates as the ileocolic artery at the 
level of the caecum. The major branches of the SMA are the inferior 
pancreaticoduodenal artery, the middle colic artery, the right colic artery, 4 to 6 
jejunal branches, and 9 to 13 ileal branches.
16
 
 
Inferior Mesenteric Artery 
The Inferior Mesenteric Artery (Fig. 3) is the smallest of the mesenteric vessels 
and arises 6 to 7 cm below the SMA at the level of L3. It supplies the hindgut: 
the distal transverse colon, splenic flexure, descending colon, and rectosigmoid. 
The IMA is a narrow-caliber artery (0.5 cm) that has a relatively acute takeoff 
angle from the aorta, rendering it much less susceptible to embolic events. The 
major branches of the IMA include the left colic, sigmoid, and hemorrhoidal 
arteries. The ascending branches of the left colic artery reach the splenic flexure 
in 80%to 85% of patients and extend to the midtransverse colon in 15% to 20% 
of individuals. At this point, they anastomose with branches of the middle colic 
artery from the SMA. The sigmoidal branches form arcades that anastomose 
with the left colic artery and superior hemorrhoidal artery.The superior 
hemorrhoidal artery supplies blood to the wall of the upper two thirds of the 
rectum and to the entire mucosa .
12,16
The middle hemorrhoidal artery arises 
from the anterior division of the internal iliac artery or from the vesical branch 
of this vessel. The middle hemorrhoidal artery traverses the infraperitoneal 
pelvis in the lateral ligaments and supplies the middle third of the rectum. The 
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inferior hemorrhoidal artery is a branch of Internal Pudendal Artery which in 
turn is a branch of the anterior division of the internal iliac artery. It is invested 
by endopelvic fascia as it exits the pelvis, below the piriformis muscle, through 
the greater sciatic foramen. It pursues a short course in the buttock and then re-
enters the pelvis. It crosses the ischiorectal fossa, which may cause considerable 
bleeding if encountered during abdominoperineal resection of the rectum.  
This vessel supplies the levator ani and sphincters in addition to the lower 
rectum and anal canal.
12–16
 The mesenteric vascular anatomy is well depicted on 
cross-sectional imaging (Fig. 4). 
 
Fig.1. Diagram of typical celiac axis anatomy. A, aorta; AIPD, anterior inferior 
pancreaticoduodenal artery;ASPD, anterior superior pancreaticoduodenal artery; 
C, celiac axis; CP, caudal pancreatic artery; DP, dorsal pancreatic artery; GD, 
gastroduodenal artery; H, common hepatic artery; LG, left gastric artery; PIPD, 
posterior inferior pancreaticoduodenal artery; PM pancreata magna; RGE, right 
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gastroepiploic artery; S,splenic artery; SM, superior mesenteric artery; TP, 
transverse pancreatic artery. 
 
Mesenteric Collateral Flow Patterns 
There are numerous sources of collateral flow between the mesenteric vessels 
and nonmesenteric systemic vessels. This redundancy imparts substantial 
protection against intestinal ischemia and infarction after segmental vascular 
occlusion. As a result of these multiple potential sources of collateral flow, at 
least two of the three main vessels must be occluded or have critical stenoses for 
MI to develop. 
 
Celiac axis–superior mesenteric artery collaterals 
At autopsy, approximately 20% of individuals have greater than 50% 
stenosis of the celiac artery.
14,15
 Most of these patients are asymptomatic 
because of the rich collateral vessels from the SMA (Fig. 5). The 
gastroduodenal and superior and inferior pancreaticoduodenal arteries are  
pathways of collateral flow between the SMA and celiac axis. The arc of 
Barkow forms potential communications between omental branches from the 
SMA and branches of the celiac axis. 
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SMA-IMA COLLATERALS: 
At autopsy, it is not uncommon for the SMA (30%) and IMA (30%) to be 
stenotic
14,15 
The marginal artery of Drummond, which lies in  the subperitoneal 
space of  mesocolon of the descending colon, consists of  the ileocolic, right 
colic, middle colic, and left colic arterial branches. An anastomosis between the 
middle and left colic arteries is present in 95% of individuals and occurs at the 
splenic flexure—the so-called ‘‘Griffith’s point.’’ 
The arc of Riolan (meandering mesenteric artery) lies within the descending 
mesocolon as well but is more centrally located and usually joins the middle 
and left colic arteries.
12,16
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Fig. 2. Diagram of typical superior mesenteric artery anatomy. A, aorta; AIPD, 
anterior inferior pancreaticoduodenal artery; COL, colic branches; I, ileal 
branches; IC, ileocolic artery; JEJ, jejunal branches; MC, middle colic artery; 
PIPD, posterior inferior pancreaticoduodenal artery; RC, right colic artery; SM, 
superior mesenteric artery. 
 
Inferior mesenteric artery–systemic circulation collaterals 
There are collateral vessels within the rectum by way of the anastomoses of the 
superior rectal chronic celiac artery occlusion, a Whipple’s operation can cause 
hepatic ischemia by interrupting collateral arterial flow from the SMA through 
the pancreaticoduodenal arcades. A segmental colectomy may interrupt critical 
anastomotic networks between the SMA and IMA and result in acute ischemia 
in patients who have severe mesenteric occlusive disease. 
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The IMA is the most frequently occluded mesenteric vessel by chronic vascular 
disease. This artery is usually sacrificed during abdominal aortic aneurysm 
repair. If the SMA is severely diseased and the midgut is receiving a large 
proportion of blood from the arc of Riolan, sacrificing this vessel during 
aneurysm repair can cause small bowel and 
right colon infarction
.16
 
 
Table 1 
Types and approximate incidences of intestinal ischemia 
Colonic ischemia 75% 
Acute mesenteric ischemia 25% 
Focal mesenteric ischemia 5% 
Chronic mesenteric ischemia 5% 
Mesenteric venous thrombosis Included in previous incidences 
Table 2 
Causes and approximate incidences of acute mesenteric ischemia 
Embolus of Superior mesenteric artery  50% 
NOMI  25% 
SMA thrombosis 10% 
MVT 10% 
Segmental ischemia 5% 
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Box 2 
Disorders associated with mesenteric venous thrombosis 
Antithrombin resistance 
Estrogen use  
Neoplasms 
Pregnancy 
Cirrhosis 
After sclerotherapy of esophageal 
varices 
Diverticulitis 
Pancreatitis 
Post operative states 
Splenectomy  
Deficiency of Methyltetrahydrofolate 
replacement therapy) 
Thrombocytosis 
Peripheral deep vein thrombosis 
Portal hypertension 
Congestive splenomegaly 
Inflammation 
Appendicitis 
Perforated viscus 
Pelvic or intra-abdominal abscess 
Blunt abdominal trauma 
Decompression sickness 
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Causes of mesenteric ischemia 
ACUTE MESENTERIC 
ISCHEMIA 
Arrhythmias 
Myocardial infarction 
Cardiac aneurysm 
Iatrogenic 
Atherosclerotic disease 
Heart failure 
Sepsis 
Medications 
Burns 
Hypercoagulable states 
Malignancy 
Compression 
CHRONIC MESENTERIC 
ISCHEMIA 
Arterial hyperplasia or dysplasia 
Emboli 
Valvular disease 
Hypokinetic ventricular wall 
Aortic atherosclerotic disease 
Thrombosis 
Nonocclusive 
Cardiac bypass 
Renal failure 
Pancreatitis 
Venous occlusion 
Sepsis 
Portal hypertension 
Pregnancy 
Atherosclerotic disease 
Inflammatory disease 
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Box.3 Causes of colonic ischemia 
IMA thrombosis 
 Arrhythmia 
Congestive heart failure 
Vasculitis 
Hematologic disorders 
Sickle cell anemia 
Factor I 2010A mutation (in 
combination 
with oral contraceptive use) 
Polycythemia vera 
Infections 
Parasites 
Angiostrongylus costaricensis 
Entamoeba histolytica 
Viruses 
Cytomegalovirus 
Bacteria 
Escherichia coli O157:H7 
Trauma 
Long-distance running 
Pregnancy 
Surgical 
Reconstruction of aorto iliac vessel 
Gynecologic surgeries 
Medications 
Related to vasoconstriction or 
vasculitis 
Digitalis 
Gold 
Pseudoephedrine 
Sumatriptan 
Cocaine 
Methamphetamine 
Nonsteroidal anti-inflammatory drugs 
Imipramine 
Related to hypovolemia or 
constipation 
Interferon-a 
Saline laxatives 
Estrogens 
Progestins 
Danazol 
Psychotropic medications 
Alosetron 
Vasopressin 
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MESENTERIC VENOUS THROMBOSIS 
Mesenteric venous thrombosis (MVT) is responsible for 5% to 15% of bowel 
ischemia. It is more common in the fifth and sixth decades of life. 
MVT includes acute, subacute, and chronic forms. Acute MVT occurs 
when the major mesenteric veins are occluded. Patients present with severe 
abdominal pain, distention, and positive fecal occult blood. Subacute MVT is 
usually caused by thrombosis of smaller mesenteric veins. This form has a slow 
insidious onset and evolves over 
days with vague abdominal pain and nausea. Chronic MVT lasts several weeks 
or months. MVT is defined as primary in cases where no apparent cause of 
mesenteric venous occlusion is evident. Secondary MVT includes all mesenteric 
venous occlusions with known predisposing conditions. 
Most cases have an identifiable cause with only 10% now characterized 
as idiopathic In 60% to 80% of MVT, a predisposing cause was identified. The 
causes of MVT include hypercoagulable states, venous stasis, and 
inflammation. Up to 50% of cases have had a deep venous thrombosis or 
pulmonary embolism before. 
 Bowel involvement in MVT is usually segmental with edema and hemorrhage 
of the bowel wall with focal exfoliation of the mucosa. Its presentation may be 
acute or chronic, generally presenting for evaluation 1 to 2 weeks after onset of 
symptoms. The diagnosis is difficult as 
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the symptoms are often nonspecific. Most patients will have abdominal pain 
(90%), but the onset is variable and location is inconsistent. Patients typically 
do not experience  the classic symptoms of postprandial pain and sitophobia 
seen in arterial thrombosis. 
Nausea and vomiting are present in 60% to 75% of patients and 30% will 
have altered bowel habits with either constipation or diarrhea. The diarrhea 
infrequently is bloody, but more than one half of patients are positive for occult 
blood. Fever is a common finding along with abdominal tenderness, distention 
with decreased bowel sounds, but peritoneal signs are seen in only two thirds of 
patients. 
As with AMI, the laboratory parameters are nonspecific. Plain films of 
the abdomen often are normal at presentation or simply show a nonspecific 
ileus. These factors all contribute to the difficulty in making this diagnosis, but 
do not lessen the importance.Mortality is directly related to timing of diagnosis 
and institution of prompt therapy.The available data suggest that the most 
common disorder is the factorV Leiden mutation (causing resistance to 
activated protein C), which is present in 20% to 40% of patients. Other 
hypercoagulable states include such hematologic conditions as antithrombin III 
deficiency, protein C and S deficiency, polycythemia vera, thrombocytosis, 
hyperfibrinogenemia, and myeloproliferative disorders. 
 Hypercoagulability is also associated with use of oral contraceptives and 
neoplasms of the gastrointestinal tract, pancreas, lung, and ovary. Patients after 
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surgery are at increased risk for MVT. Splenectomy is the procedure with the 
highest risk for MVT. Most MVTs occur within 1 month after splenectomy. 
Abdominal trauma, abdominal inflammation, peritonitis, and portal 
hypertension are other risk factors for MVT. 
Acute MVT has high incidence of recurrence (33%–40%) in the early 
postoperative period, so that many clinicians perform a second-look operation 
either routinely or selectively. In the case of selective second-look operations, 
the choice to perform a second-look procedure is based on the lack of clear 
demarcation zones at the first operation, leaving questionable zones of intestine 
not resected and left for observation.MVT without peritoneal signs can be 
managed conservatively. Early systemic anticoagulation with heparin is the 
main nonoperative treatment. 
 
Non occlusive mesenteric ischaemia (NOMI) 
NOMI accounts for 20% to 30% of acute mesenteric ischemic events, and, as 
with other types of AMI, carries a high mortality rate of 50% to 90%.  NOMI 
refers to ischemia secondary to a low flow state in the absence of arterial or 
venous occlusion. 
The decrease in cardiac output is associated with a diffuse mesenteric 
vasoconstriction which further reduces flow, leading to ischemia and ultimately 
necrosis.  NOMI occurs mostly n the intensive care setting. These patients 
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suffer from either cardiogenic or septic shock. The use of inotropic agents such 
as noradrenalin (alpha agonist causing generalised vasoconstriction) aggrevate 
the mesenteric. Long term dialysis patients are another at high risk for NOMI. 
The severe and rapid fluid shift associated with the dialysis is contributory to 
the abdominal symptoms 
27, 28
.  
Clinical symptoms are often missed as the patients with NOMI may be 
critically ill and the onset of symptoms is often insidious. The risk increases 
further if the patients are receiving  enteral nutrition. The increased demand 
generated by the enteral feedings may exceed the capacity of blood flow to meet 
the metabolic requirements Watershed areas of mesenteric circulation in the 
region of the splenic flexure tend to be affected with NOMI. Another group 
which is vulnerable to NOMI is the surgical post-operative or polytrauma 
patient receiving enteral feeding in the intensive care unit.  
The reported incidence of AMI in this group is 0.3 to 8.5% 
11
. The 
increased demand from enteric feeding fails to be met by the systemic 
hypoperfusion and the mesenteric vasoconstriction. The diagnosis is difficult to 
make since the patients are often unable to alert the attention to the abdomen. 
Before this entity was recognised, the mortality was nearly 100% in cardiac 
patients following use of vasopressors, but the mortality associated with NOMI 
has decreased with increasing awareness and increasing use of vasodilators and 
afterload – reducing agents. 
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A series of autopsies were reviewed to assess the incidence of NOMI, the 
extent of involvement, and the potential risk factors.
18
 The incidence was rare, 
yet increased in octogenarians from 2/100,000 person-years before age 80 to 
40/100,000 personyears after age 80. Only 29% were correctly diagnosed before 
death, again verifying the difficulty in making an early diagnosis. The 3 major 
potential causes in this series were heart failure, atrial fibrillation, and recent 
major surgery. Forty percent of fatal cases of NOMI were found to have 
mesenteric stenosis which further contributed to the low flow state. 
As with other forms of AMI, early laboratories and the abdominal flat plate 
show little change or are nonspecific. A high index of suspicion is required and 
NOMI should be considered in those patients who develop unexplained clinical 
deterioration or failure to thrive while recovering from a cardiac event or major 
surgery. 
Iatrogenic intestinal ischaemia 
Visceral malperfusion may result following post cardiac surgery related 
intra- aortic balloon pumps orother interventional radiological procedures of the 
aorta. Global involvement of the viscera, lowerlimbs, kidneys and pelvis  may 
occur because of embolisation and hence is associated with high mortality. 
There is no ideal treatment but can be supplemented with intravenous 
anticoagulation, prostacyclin infusion and appropriate fluid resuscitation. 
Esonophilia in the peripheral smear may evoke suspicion of cholesterol emboli. 
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This can occur in patients undergoing anticoagulation,systemic thrombolysis 
and aortic manipulation.With anticoagulation being contraindicated, statins are 
used to stabilise the plaque.Fever and systemic shock in the setting of 
leucocytosis with counts more than 20000 evokes a strong suspicion of severe 
colonic ischemia. 
Bowel obstruction describes a wide variety of disease processes, some of  
which require urgent surgical management and others which may at least 
initially be managed nonoperatively. In 1994 more than 300,000 patients 
underwent adhesiolysis, most of which were for bowel obstruction. Considering 
that as many as 80% of cases of bowel obstruction are managed nonoperatively, 
this represents a small fraction of the patients admitted with bowel obstruction. 
Bowel obstruction is generally classified based on whether it involves the small 
or large bowel, whether it is a mechanical or functional obstruction, and, in the 
case of mechanical obstruction, if it is partial or complete. 
 Classification of the obstruction based on these 3 criteria helps formulate 
important management decisions. Small bowel obstruction usually presents with 
abdominal pain, often colicky,nausea, vomiting, and lack of flatus. If ischemia 
is present the pain may have the classic quality of being out of proportion to 
tenderness on physical examination. Small bowel obstruction is most commonly 
caused by adhesions (up to 75% of cases), but may also be caused by hernia, 
malignancy, inflammatory bowel disease, ischemia, intussusception, infections, 
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radiation, graft-versus-host disease (GVHD), intramural hemorrhage, stones 
(gallstones, enteroliths), Meckel’s diverticulum, and other generalized 
inflammatory disorders such as lupus. Important historical questions include 
prior abdominal surgery, inflammatory bowel disease, cancer, radiation, pelvic 
inflammatory disease, endometriosis, or other intestinal disease. Examination is 
important to assess the degree of abdominal distension, tympany, tenderness, 
bowel sounds, and location and quality of scars, as patients are often poor 
historians in terms of prior surgery. 
 The presence of hernia should be carefully excluded. The degree of 
distension may give a clue as to the location of the obstruction, as distension 
increases with more distal obstructions. Hernia and distension are often difficult 
to assess in obese patients. Rectal or stomal digital examination is mandatory in 
patients who have not had recent surgery in these areas to identify stool or 
malignancies as the causative factors. 
The diagnostic algorithm should focus on the classification of the obstruction as 
well as on determining the likelihood of ischemia. A complete blood count 
(CBC) to assess for leukocytosis and lactic acid assists in the identification of 
ischemia, although these are neither sensitive nor specific for mesenteric 
ischemia. Azotemia and electrolyte abnormalities are common and in the case 
of ileus may contribute to the pathophysiology. 
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The blood counts should be obtained to help assess the degree of volume 
depletion present in these patients and to assist in fluid resuscitation and 
electrolyte repletion. Women of child-bearing age should have at least a 
qualitative b-human chorionic gonadotropin  (b-hCG) measurement.  
Pathophysiologic changes secondary to aging cause an increased 
susceptibility to intra-abdominal diseases, as well as atypical clinical 
presentations. These changes occur from cellular to systemic levels, especially 
in the immune, genitourinary (GU), gastrointestinal (GI), nervous, and 
cardiovascular systems. Older adults are at a higher risk for more frequent and 
severe infections due to immunosenescence. Aging of B cells decreases the 
ability to develop humoral (antibody) immunity to new infections or antigens, 
thereby increasing the risk for recurrence. The T cell response also changes with 
aging, with decreased quantity and quality of the T cells and a decreased 
immune response to known antigens,possibly because of changes in the 
phenotype towards more immunosuppressive T cells.These derangements have 
consequences for interpretation of the white blood cell count; on the one hand, a 
low count does not exclude an acute inflammatory condition, on the other, an 
elevated count does not exclude functional immunodeficiency. 
Aging is associated with a decreased response to pyrogens, lower basal 
body temperature, changes in thermal homeostasis, and a decreased production 
and conservation of heat. In one study, 30% of older adults who had surgical 
abdominal pain did not present with either a fever or 
30 
 
leukocytosis.Immunosenescence also results in decreasing immunosurveillance, 
the body’s main defense against developing cancerous cells. 
Renal changes with aging include decreased numbers of glomeruli and 
decreased glomerular function. These changes are caused by both long-term 
damage from comorbidities, such as hypertension and diabetes, and 
dysautoregulation of the afferent and efferent arterioles resulting in glomerular 
damage. Glomerular filtration rate decreases with age starting in the fourth 
decade and then diminishes by about 8 mL/min/decade, resulting in a reduction 
in the clearance of drugs and metabolites. Changes to the basement membrane 
and the development of small diverticula in the distal renal tubules promote 
urinary stasis and bacterial growth.The aging kidneys also have diminished 
ability to concentrate urine, making older adults more prone to dehydration. 
Hormonally, the kidneys have reduced production of epoetin, inclining the older 
adult toward anemia from slow losses of blood. 
The effects of aging on the GI system also predispose patients to 
abdominal pathologic conditions. The stomach has a slightly decreased 
emptying time and fundal compliance. Acid secretion may increase secondary 
to decreased prostaglandin production. Liver mass and liver blood flow 
decrease with aging, resulting in decreased albumin synthesis and decreased 
phase 1 drug metabolism. The decrease in cytochrome P450 function and drug 
metabolism may be even greater in older men than in older women.
10
 In the 
colon, the number of diverticula in the bowel increases with age. Because of 
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physiologic anorexia of aging, there is decreased fluid and nutrient intake, 
predisposing the older adult to constipation.
11,12
 Reduced physical activity for 
just 2 weeks almost doubles total colonic transit time in older adults, which may 
contribute to the higher rate of postoperative ileus in this population. 
Both the central and peripheral nervous systems are affected by aging. The 
prevalence of dementia and cognitive impairment increases, obscuring 
symptoms and obfuscating the medical history. Peripherally, pain and 
temperature sensation decreases as the type of pain sensing nerves slowly 
switches from A delta fibers (fast, sharp, prickly pain) to a reliance on slower-
conducting C fibers.This sensation decrease may contribute to the lack of 
peritoneal signs in many older adults.  
 
ISCHEMIC COLITIS 
Intestinal ischemia presents itself in most cases as ischemic colitis representing 
about       50%-60% of cases. Ischemic colitis can be gangrenous or 
nongangrenous. The latter amounts to   81% to 85% of the cases and include 
transient and chronic forms.37. In the nongangrenous transient type, there is 
edema, hemorrhage, and possible necrosis of the mucosa and submucosa. This 
form usually resolves with a complete anatomic and functional recovery in 2 
weeks. The nongangrenous chronic form usually extends to the muscularis 
propria. Fibrous tissue usually replaces the damaged muscularis propria, 
resulting in colonic strictures. Gangrenous forms comprise the 15% to 20% of 
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cases of ischemic colitis and are characterized by transmural necrosis, evolving 
in sepsis and usually requiring surgical resection.  
An acute decrease in the colonic blood supply is usually the cause of 
ischemic colitis. In most cases of ischemic colitis, the cause is not apparent 
(idiopathic). 
Known causes of ischemic colitis include: 
Mesenteric vascular occlusion 
Shock 
 Medications (digitalis, catecholamines, estrogen,danazol, gold, 
nonsteroidal anti-inflammatory medications, neuroleptics, 
           diuretics and laxatives) 
Cocaine 
Colonic obstruction 
Infection with Escherichia coli 
Vascular occlusion may be related to thrombosis, embolization, trauma, 
radiologic procedures, or surgical procedures. Small vessel disease may 
be caused by diabetes mellitus, rheumatoid arthritis, or vasculitis. 
Colon ischemia is described as a complication of abdominal aortic surgery in 
0.2% to 10% of cases. It is five times more frequent after abdominal aortic 
aneurysm repair. In  aortic occlusive disease, the IMA is usually occluded and 
an adequate collateral circulation to the left colon is already established before 
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surgery. In patients with aneurysm of the abdominal aorta, intraoperative IMA 
ligation can cause ischemia of the left colon in case of inadequate collateral 
flow. Risk factors for colon ischemia after abdominal aortic aneurysm repair 
include prolonged cross clamp time, reoperative procedures,ruptured 
aneurysms, hypoxemia, and hypotension. Colon involvement is usually 
segmental. The entire colon may be affected. The most commonly involved 
areas are the sigmoid colon and splenic flexure. Because of the vascular 
anatomy of the colon, two places are at particular at risk for ischemia: Griffith’s 
point( splenic flexure ) and Sudek’s point (sigmoid ). The sigmoid colon is 
involved in 75% of cases, the splenic flexure in 25%, and the right colon in 
10%. A predisposing factor to colon ischemia is the absence of a marginal 
artery of Drummond at the splenic flexure. 
This artery is absent in 7% of the population. Ischemic colitis affects 
mostly the retroperitoneal surface of the right colon in hypovolumic states. 
Patients with ischemic colitis are usually elderly and complain of acute 
abdominal pain, diarrhea, and hematochezia. The blood loss is usually 
small.The physical examination is remarkable for mild abdominal distention 
and localized tenderness. The definitive diagnosis of ischemic colitis is based on 
colonoscopy. 
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OTHER MESENTERIC ISCHEMIC SYNDROMES 
The celiac artery compression syndrome includes all cases of  celiac artery 
compression (external) because of median arcuate ligament or celiac ganglia 
involvement. Patients usually complain of postprandial abdominal pain, 
positional abdominal pain,nausea, and weight loss. 
Mesenteric vessels may be involved in vasculitis with consequent bowel 
ischemia. Vasculitis may affect the main arteries, medium-sized arteries or the 
small vessels.Cocaine abuse is responsible for both acute and chronic ischemic 
episodes. Chronic ischemia may be due to occlusion of both the superior 
mesenteric artery and celiac artery. 
Radiographic evaluation begins with supine and upright views of the 
abdomen. These films should be evaluated for bowel dilatation, colonic and 
rectal air, and air fluid levels. Often the transition point, that is, the location of 
obstruction, can be determined based on these radiographs alone,although the 
sensitivity of plain films is low (40%–80%). CT scanning has become a 
standard imaging modality for bowel obstruction as it has a sensitivity of 94% 
to 100% and specificity of 90% to 95%.Current CT technology with multiplanar 
reformats provides greater diagnostic confidence in terms of location and cause 
of obstruction. CT may determine whether the obstruction is complete or 
partial, and the presence of a closed loop obstruction or intestinal ischemia. 
Signs of ischemia on CT scan include thickened bowel wall, pneumatosis 
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intestinalis, absence of wall or vascular enhancement, portal venous gas, ascites, 
and inflammatory changes in the fat.  
The results of CT imaging often change the management of bowel 
obstruction, and should therefore be used in cases where diagnosis is in 
question, or obstruction fails to resolve rapidly with nonoperative management. 
Small bowel follow-up studies have been reported to result in more frequent and 
rapid resolution of bowel obstruction, but this was not confirmed in a recent 
meta-analysis. 
Initial management of the patient should focus on fluid resuscitation and 
the concept that the patient is being prepared for surgery. Medical management 
should focus on the patient’s underlying comorbidities. Fluid resuscitation 
should be guided based on hemodynamic response and urine output. Monitoring 
of urine output is critical,and if there is any question of adequate urine output a 
Foley catheter should be placed. For patients with emesis, a nasogastric tube for 
decompression can provide symptomatic relief. Antiemetics can be 
administered judiciously, but for patients at risk for aspiration, nasogastric 
decompression is more prudent. Prophylaxis for deep venous thrombosis should 
be administered as these patients will often be bed-bound or destined for 
surgery. There are no data available regarding antibiotic administration except 
for immediate preoperative prophylaxis or in the setting of a known infectious 
cause. Standard therapy for mechanical small bowel obstruction is prompt 
surgery. This is especially true for patients with clinical signs of bowel ischemia 
36 
 
including fever, leukocytosis, peritonitis, acidosis, patients with radiographic 
signs of a closed loop obstruction or bowel ischemia, or patients with a 
complete obstruction. Patients with a partial obstruction, those in the immediate 
postoperative period, and those with obstruction from primary bowel 
inflammation such as inflammatory bowel disease or GVHD can generally be 
managed nonoperatively, as small bowel obstruction has been reported to 
resolve in up to 81% of cases without operation. Bowel obstruction that fails to 
resolve with nonoperative management after 48 hours will generally not resolve 
with more prolonged periods of observation. Although no study has 
demonstrated worsened mortality with delay in operation for patients without 
intestinal ischemia, it may be more likely to result in morbidity and the need for 
bowel resection. 
Although laparoscopic or open approaches are feasible, laparoscopy has 
been reported to be a successful operative modality in 60% of patients requiring 
operative intervention, with a conversion rate to an open procedure of 20% to 
65%.Large bowel obstruction is most commonly due to neoplasm. Other causes 
include inflammation/infection, volvulus, stricture, intussusception, and fecal 
impaction.Colonic obstruction typically presents with abdominal pain, 
abdominal distension,and obstipation. Complications such as ischemia and 
perforation are, as in small bowel obstruction, heralded by fever, leukocytosis, 
tachycardia, and peritonitis on physical examination. Diagnosis by plain 
radiographs has 84% sensitivity and 72% specificity, whereas CT scanning 
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provides valuable diagnostic information in terms of cause and location. Initial 
management is centered on resuscitation and correction of electrolyte 
abnormalities. Unlike with small bowel obstruction, emesis is uncommon and 
the need for nasogastric decompression is also less common. Definitive 
management is usually surgical, although for malignant obstructions colonic 
stents may be useful in cases of poor surgical risk or widely metastatic disease. 
Volvulus may be reduced endoscopically, which is usually successful in cases 
of sigmoid volvulus but less so in cecal volvulus. Surgical resection is 
mandatory in cases of recurrence and should be considered after successful 
reduction due to high recurrence rates. Patients with obstruction due to acute 
diverticulitis or other acute infectious causes should be treated with antibiotics, 
percutaneous drainage of abscesses, and careful monitoring of colonic diameter 
and serial abdominal examinations for signs of peritonitis. 
Acute colonic pseudo-obstruction, Ogilvie syndrome, is a pancolonic 
dilatation without mechanical obstruction. The pathogenesis of this disorder is 
believed to involve autonomic dysregulation and occurs most commonly in 
association with another acute illness. Management generally involves fluid 
resuscitation and bowel rest with rectal decompression and nasogastric 
decompression. Narcotic and anticholinergic medications should be minimized. 
Although absolute cecal diameter is often implicated as determining the risk of 
perforation, the major risk factor is duration of overdistension in patients with a 
cecal diameter greater than 10 cm.  
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Therefore, in addition to the interventions mentioned earlier, therapy with 
an acetylcholinesterase inhibitor or colonoscopic decompression should be 
undertaken if there is no clinical improvement within 24 hours. In a randomized 
controlled crossover trial design, neostigmine resulted in a 94% success rate in 
improving abdominal distension and a low rate of recurrence, with 11% 
developing recurrent colonic distension.  
Success rates for colonoscopic decompression vary from 61% to 95%. 
Surgery is indicated for failure of less invasive modalities and generally 
includes resection with or without reanastomosis if contamination is present at 
operation. Open and percutaneous cecostomy have been described but 
significant complications of these procedures have also been noted. 
 
PATHOLOGIC FINDINGS OF INTESTINAL ISCHEMIA 
Small Bowel 
Pathologic evidence of small bowel ischemia and infarction (Figs. 6–8) 
may be diffuse and widespread or patchy and in multiple areas. The serosa of 
the affected small bowel often appears congested or blue and black. Perforations 
may be present but may not associated with well-developed fibrinous exudates 
if the surgical resection occurs within a short time of presentation. The 
mesentery is usually pale in arterial occlusions and congested and hemorrhagic 
in venous occlusion. The demarcation between normal and involved gut is 
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usually abrupt.The lumen of the intestine is always filled with blood and the 
surface of the mucosa may appear boggy, red and ulcerated and contains 
irregularly protruding islands of mucosa.The above phenomenon is responsible 
for the thumbprinting sign. Transmural hemmorrhage and pseudomembranes 
might be evident. The invoved segment shows friable and thin wall.Gross 
examination of the mesenteric veins in mesenteric venous thrombosis may show 
evident thrombi. Submucosal edema, congestion and hemorrhage may be seen 
along with preservation of the overlying mucosa in some instances. 
Formation of pseudomembranes, luminal hemorrhage, necrosis of the 
mucosa with or without ulceration are seen in various degrees of submucosal 
involvement. There is absence of chronic inflammatory response in an acute 
episode, nevertheless neutrophils may be seen if significant time has passed 
since occlusion.
14,15
. Loss of villi occur progressing from villi tips to the cryptal 
bases and associated with varying degrees of congestion and edema.Neutrophils 
occur in the damaged areas within hours of the initial ischemic event. If the 
ischemic process stops, the changes in the mucosa may revert to normal, but it 
all depends on the extent and severity of the injury. When ischemia is persistent 
or severe, stricture formation and fibrosis may result in the process of tissue 
healing.
14,15
. Confusing are results of mesenteric vascular evaluation as thrombi 
may result due to congestion and prolonged stasis. When thrombi are present 
for a prolonged time, thrombi show evidence of organisation.Small arterioles 
may show evidence of fibrin thrombi in areas of necrosis but they do not 
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necessarily indicate vasculitis or a hypercoagulable state.
14,15
.  Deeper portions 
of the colonic crypts show evidence of necrosis sparing the superficial portions 
in acute ischemic episodes of the colon. 
Evident cytological atypia in the remaining crypts which show atrophic or 
withered appearance may resemble dysplasia. Lamina proprial hemorrhage , 
laminal proprial hyalinisation and pseudomembrane formations may also be 
seen. These lesions come down on their own or florid gangrene with perforation 
or formation of stricture can occur. The chronic phase of colonic ischemia may 
be very difficult to diagnose as non specific hiatological findings like stricture 
formation and submucosal fibrosis may only be evident.
14,15
 
 
CLINICAL FEATURES OF MESENTERIC ISCHEMIA 
 No physiological or biochemical methods of detecting ischemia and 
predicting its outcome have been proven till date. Cell hypoxia may reveal itself 
as increased serum lactate but lactic acidosis occurs only with circulatory 
collapse and bowel necrosis in the later stages only. 
Plasma D-dimer levels is coming up as an early marker in acute ischemic 
events. It has been shown to have good correlation with onset of ischemia and 
function thus indicating disease progression as evident in animal studies. 
 Alcohol dehydrogenase enzyme levels is a sensitive indicator of bowel 
ischemia when compared with generalised systemic hypoperfusion. Glutathione 
S-transferase with its several isoforms which are associated with bowel 
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specificity have been released with cell membrane damage. It increases with 
considerable rates with progressive tissue ischemia.   
 
 
 
Acute Mesenteric Ischemia  
Acute mesenteric ischemia is caused by an abrupt reduction of either 
arterial or venous blood flow to the gut, and is associated with a high mortality 
and morbidity rates requiring urgent diagnosis and treatment.32 Almost all 
patients present with severe pain abdomen. The onset of pain is usually sudden 
in patients with emboli as the cause. On the other hand, patients with thombotic 
etiology may have a more insidious onset of symptoms. 
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Nausea, vomiting, and diarrhea are also common complaints.
32
 
CTA is an excellent modality to evaluate patients with suspected acute 
mesenteric ischemia. CT in combination with 3D CTA can evaluate the 
mesenteric vasculature as well as bowel enhancement, and is therefore a 
comprehensive study. Thereare 4 major causes of acute mesenteric ischemia: 
SMA embolus, SMA thrombus, mesenteric venous thrombus, and 
nonocclusive mesenteric33 ischemia.
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Acute emboli to the SMA are the most likely origin of AMI, occurring in 
41% to 50% of cases.
35
 Most of the emboli originate in the heart and will lodge 
in the Superior Mesenteric Artery a few centimetres distal to origin, mostlikely 
near the origin of the middle colic artery. Small emboli lodge more distally and 
mostly affect only small bowel segments.
35,36
 The arterial thrombus is visible as 
a low-density filling defect on CT. Proximal thrombi are best visualized on the 
sagittal reconstructions,while distal thrombi may only be visible using volume 
rendering with comprehensive interrogation of all the distal mesenteric branches 
37
 Regardless of the cause of the ischemia, the affected small bowel loops may 
be dilated and fluid filled, as a result of an interruption in normal peristalsis and 
increased secretions. The wall may be thickened, but in some cases will actually 
be normal or thinned . Ischemia usually causes bowel wal circumferential 
thickening. The bowel wall that is ischemic is typically to 8 to 9 mm thick, but 
in some cases becomes as thick as 1.5 cm. Bowel wall thickening is important 
in cases of  thrombosis of veins than in cases of arterial thrombosis. Therefore, a 
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bowel wall measuring 1.25 cm, in the setting of  ischemia, most likely signals 
obstruction of venous blood flow. Complete lack of mural enhancement has 
been reported but is an unusual finding, given the redundant blood supply to the 
gut. The bowel wall may appear of low density, reflecting decreased perfusion. 
Fig. 3. An 80-year-old man presenting with pain abdomen. (A) 
Sagittal MPR and (B) Coronal MIP show a large thrombus in the mid 
SMA (arrow); this was embolic, presumably from a cardiogenic source. 
Surgical embolectomy was performed. 
 
F.g.3 
 
 
F.g.4 
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Fig. 4. An 80-year-old woman with an acute small bowel obstruction. (A) 
Coronal MPR and (B) sagittal MPR show fluid-filled small bowel loops that are 
dilated. The wall appears thinned and has decreased enhancement (arrows) 
compared with the more proximal and unaffected small bowel loops 
(arrowheads). 
Edema, or may appear increased in density relative to normal bowel 
loops,related to hemorrhage or hyperemia. The halo sign may be present. 
Intramural hemorrhage may be present,and is often only appreciated if 
noncontrast scans are obtained.  After intravenous contrast is administered, 
intramural hemorrhage may be misinterpreted as enhancement.  Pneumatosis is 
a late finding, indicating transmural infarction, and may be accompanied by air 
in the mesenteric veins and/or portal vein (Fig. 5). In patients with acute arterial 
ischemia, there may be stranding in the mesentery and ascites, also indicating 
severe ischemia and usually transmural infarction. Thrombosis of the SMA 
usually occurs in atherosclerotic disease, because of rupture of an unstable 
atherosclerotic plaque. 
Thrombosis of the Superior Mesenteric Artery is thought to be 
responsible for up to 30% of all cases . Unlike emboli, thrombi typically 
develop at the origin of the SMA and within the first 2 cm, best visualized using 
sagittal reconstructions. There is usually a combination of calcified plaque with 
superimposed thrombus. Because SMA thrombosis often occurs in the setting of 
patients with chronic ischemia, there may be associated arterial collaterals, 
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which can be visualized well using CTA. Another well known cause of acute 
mesenteric ischemia is mesenteric venous thrombosis (see later discussion). 
Nonocclusive mesenteric ischemia is thought to represent up to 25% of 
cases and is associated with a high mortality rate, up to 70%.43 NOMI occurs in 
hypotension or hypovolumic shock. Severe hypoperfusion of the gut will cause 
severe vasooconstriction of the mesenteric arteries. The findings on CT may be 
subtle.  
 
Fig. 5. Postpartum female ( 37 years) with severe pain abdomen. Axial contrast-
enhanced CT with soft tissues windows (A) and lung windows (B) shows a 
small bowel obstruction and pneumatosis (arrows). F, large necrotic uterine 
fibroid. 
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Fig. 6. An 83-year-old with pain abdomen . (A) Sagittal MIP shows extensive 
calcified atherosclerotic disease involving aorta and proximal SMA (arrow). (B) 
There is also a filling defect in the proximal SMA (arrows), which is acute 
thrombus that has form in a region of calcified plaque. 
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Fig. 7. A 65-year-old man in cardiogenic shock after an acute myocardial 
infarction. (A) Axial contrast-enhanced image through the mid abdomen 
shows dilated small bowel and colon as well as poor perfusion of the 
kidneys.(B) Axial contrast-enhanced image shows a small-caliber SMA 
(arrow). A right pleural effusion is also present. (C) Sagittal MIP image 
shows the small-caliber celiac axis and SMA, a typical finding in patients 
with hypotension. 
Fig.7 
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its branches will appear small in caliber and there may be delayed opacification 
of the mesenteric veins. The bowel is often dilated and fluid filled. The bowel 
wall may also be thickened.
35–37
 In severe cases pneumatosis or portomesenteric 
venous gas is present, indicating transmural infarction, which carries a dismal 
prognosis. 
In patients with suspected infarcted bowel from emboli, explorative 
laparotomy with resection of the ischemic bowel  and thus re establishing 
vascularity to the bowel.  
However, advancements in interventional radiology techniques offer an 
effective, less invasive therapeutic alternative for patients with ischemia but no 
clear evidence of infarcted bowel. Arterial thrombolysis, angioplasty, and 
placement of stent are all available and effective. Venous thrombosis can be 
treated with systemic, anticoagulation, or percutaneous transhepatic delivery of 
thrombolytics. 
Nonocclusive mesenteric ischemia can often by treated with selective 
arterial administration of vasodilating agents (ie, papaverine). Patients with 
ischemia resulting from thrombus forming in the setting of chronic mesenteric 
ischemia may require a combination of percutaneous and systemic therapies, 
and ultimately may need stenting or surgical revascularization. 
Chronic Mesenteric Ischemia: 
Atherosclerotic phenomenon in severe stages almost always results in 
chronic mesenteric ischemia , involving the mesenteric arteries, and therefore 
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occurs in older patients. It  accounts for approximately 5% of all mesenteric 
ischemic illnesses, but ends in significant morbidity and mortality. Although 
atherosclerotic disease can often involve the mesenteric arteries, chronic 
mesenteric ischemia is actually a relatively uncommon but an important cause 
of abdominal pain in elderly patients. Even in the absence of symptoms, patients 
may have clinically significant atherosclerotic disease affecting the mesenteric 
arteries. Up to 18% of patients older than 65 years have greater than 50% 
stenosis of 
a mesenteric artery, usually withosut symptoms. Patients with significant 
atherosclerotic stenosis of the mesenteric arteries will usually only become 
asymptomatic when least 2 of 3 major mesenteric vessels, typically the SMA 
and celiac artery, become severely stenotic or occluded.  
Longterm studies have shown that as many as 86% of asymptomatic 
patients with greater than 50% stenosis of the mesenteric arteries eventually 
develop symptoms. Mortality is approximately 40%. Standard treatment for 
chronic mesenteric ischemia involves revascularization, which can be surgical 
or catheter based.  
After surgical treatment, the recurrence rate of mesenteric ischemia 
symptoms at 3 years is approximately 11%. Percutaneous interventions include 
embolectomy,thrombolysis, angioplasty, and stenting. In patients with chronic 
mesenteric ischemia, CT will show significant occlusion of minimum of two of 
the major mesenteric arteries , usually the celiac trunk and SMA. The stenosis is 
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usually at the origin and may be a combination of calcified and noncalcified 
plaque. Because the process develops over a long period of time, collaterals are 
present. CTA and volume rendering in particular are especially valuable in 
detecting and quantifying the degree of stenosis and displaying the collaterals.
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This technique can be used as a road map for the surgeon or interventional 
radiologist. 
 
VENOUS PATHOLOGY 
Mesenteric Vein Thrombosis 
Mesenteric vein thrombosis (MVT) accounts for 5% to 15% of all 
mesenteric ischemias. Thrombosis usually involves the SMV, only rarely 
involving the IMV.
35
 MVT can be classified as either primary or secondary.
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Primary or idiopathic MVT results when no underlying etiology can be 
identified. Secondary MVT is more common. Common  causes include 
underlying coagulopathy, either hereditary or acquired. Hereditary factors 
include Factor III deficiency, deficiencies in protein C, protein S, or 
antithrombin, or patients with polycythemia vera. Acquired coagulopathy is 
often related to cancer, intra-abdominal inflammatory conditions, postoperative 
patients, oral contraceptives, cirrhosis and portal hypertension, or patients with 
pancreatitis, sepsis, or after splenectomy.
35
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The increased incidence in postoperative patients may be the result of 
transient hypovolemia or release of tissue thromboplastins at surgery. In a 
retrospective study by Warshauer and colleagues. 11 of 43 patients with SMV 
thrombosis were status post partial or total colectomies. Clinical presentation 
varies depending on the location, extent, and cause of the thrombosis. Patients 
can present with acute, subacute, or chronic symptoms. Acute presentation can 
often mimic the presentation of acute arterial ischemia. In acute presentations, 
patients present with severe pain and there is a high risk of both ischemia and 
infarction. Outcomes vary, based  342 on the extent of thrombosis. Complete 
thrombosis carries a poor prognosis, as does extension of thrombus into other 
veins. Acute thrombosis can result in venous hypertension depending on the 
residual drainage from the intestines. Severe venous hypertension will 
compromise the viability and perfusion of the bowel.
35
 On CT, thrombus will be 
visible in the mesenteric veins, typically associated with engorgement of the 
veins 
35
 The walls of the veins may be thickened with increased enhancement. 
Stranding in the mesentery and ascites are also often present. The bowel wall is 
usually thickening, often related to the venous obstruction. There may be 
decreased enhancement of the wall, or in some patients there may be increased 
enhancement due to hyperemia. A halo pattern has also been described.
35
 
Complete lack of bowel enhancement is uncommon, but does signify transmural 
infarction, especially when there is accompanying pneumatosis or 
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portomesenteric gas.
35
 In subacute situations, patients may have abdominal 
pain, but typically do not show associated signs of ischemia, likely related to the 
development of collaterals.  
Treatment in acute and subacute cases usually includes anticoagulation, 
alone or in combination with surgery.
35
 Conservative treatment usually consists 
of anticoagulation, supportive measures, and bowel rest. Surgery may be 
required in patients with peritonitis and signs of ischemia/ infarcted bowel. 
Surgery may include resection of the small bowel, although the goal is to 
conserve as much bowel as possible. In select cases, thrombectomy or 
mechanical and percutaneous clot lysis can be performed. Overall, MVT carries 
a high mortality rate (20%–50%). The principal cause of the high mortality is 
delay in diagnosis. The condition is often misdiagnosed as gastroenteritis, small 
bowel obstruction, or  inflammatory bowel disease. Even after treatment there is 
a high rate of occurrence, most commonly in the first 30 days after treatment. 
Chronic MVT, often in cirrhotic patients, typically causes little symptoms 
because of the development of an extensive collateral network.  
However, these patients are at increased risk for GI bleeding related to 
the presence of the collaterals. In patients with chronic MVT, treatment may 
include propranolol to help decrease the risk of variceal bleeding. 
On CT, chronic MVT will appear as a low-density intraluminal clot. 
Enlargement of the vein and bowel wall thickening, as well as mesenteric 
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stranding and edema are typical associated findings. Multiple veins may be 
involved. Venous collaterals may also be present. 
 
Fig. 8. An 80-year-old man with abdominal pain and history of Osler-
Weber-Rendu syndrome. (A) Contrastenhanced axial CT shows small bowel 
thickening (arrows). (B) Axial image through the superior mesenteric vein 
shows a large clot (arrow). (C) Axial contrast-enhanced image through the mid 
abdomen shows extensive thrombus (arrows) in the branches of the SMV. 
Fig.8 
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RESULTS: 
 
The following pie diagram illustrates the disease distribution in various vessels. 
Disease distribution
SMA, 16
SMV, 6
Aorta  & SMA,2
Portal V & SMV, 3
IMA, 1 IMV, 1
Total positive cases 29
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The agewise distribution of mesenteric oschemia is illustrated in the above 
table. 
 
 
 
 
  
31-40
41-50
51-60
61-70
1 
12 
15 
1 
Age distribution - Ischemia 
Ischemia
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Radiographic evidences of the involved vessels are to follow: 
 
 
SUPERIOR MESENTERIC VEIN AND ITS BRANCHES. 
 
 
  
 
 INVOLVEMENT OF SMA AND AORTA 
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INFERIOR MESENTERIC VEIN  
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PORTAL VEIN & SMV INVOLVEMENT
 
 
 
SMA INVOLVEMENT  
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SMA AFTER STENTING 
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The statistical analysis illustrating the relationships between mesenteric 
ischemia and the various risk factors is illustrated below: 
MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 25 7 32 
SMOKING (-) 4 20 24 
  29 27 56 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
18.36 0.00001830 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 16.65 4.499, 74.16¹  
  3.946, 90.76¹  
Odds Ratio 17.86 4.575, 69.7¹  
Etiologic fraction in 
pop.(EFp|OR) 
81.38% 63.94, 98.82 
Etiologic fraction in 
exposed(EFe|OR) 
94.4% 78.14, 98.57 
  
Smokers 
86% (25) 
Non-Smokers 
14% 
Smokers 
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Parameter  Estimate Lower - Upper 95% CIs 
Sensitivity 86.21% (69.44, 94.5¹ ) 
Specificity 74.07% (55.32, 86.83¹ ) 
Positive Predictive Value 78.13% (61.24, 88.98¹ ) 
Negative Predictive Value 83.33% (64.15, 93.32¹ ) 
Diagnostic Accuracy 80.36% (68.16, 88.66¹ ) 
Likelihood ratio of a 
Positive Test 
3.325 (2.482 - 4.455) 
Likelihood ratio of a 
Negative Test 
0.1862 (0.1102 - 0.3146) 
Diagnostic Odds 17.86 (4.574 - 69.71) 
Cohen's kappa 
(Unweighted) 
0.6051 (0.3447 - 0.8655) 
Entropy reduction after a Positive Test 16.72%   
Entropy reduction after a Negative Test 24.19%   
Bias Index 0.05357   
 
From the table, it is clearly evident that there is statistically significant 
correlation between smoking and mesenteric ischemia. 
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 MESENTERIC 
ISCHEMIA 
  (+) (-) 
 (+) 25 1 26 
POSTPRANDIAL 
PAIN 
(-) 4 26 30 
  29 27 56 
 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
35.02 <0.0000001 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 96.15% 79.55, 100 
Risk in Unexposed 13.33% 4.695, 30.29 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 7.212 2.887, 18.01¹  
Risk Difference 82.82% 68.59, 97.05°  
Etiologic fraction in 
pop.(EFp) 
74.25% 53.23, 95.27 
Etiologic fraction in 
exposed(EFe) 
86.13% 65.36, 94.45 
 
 
 
 
Post-Prandial 
Pain 
86% (25) 
No pain 
14% (4) 
Post-Prandial Pain 
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Point Estimates  Confidence 
Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 135.6 18.78, 3464¹  
  15.44, 6909¹  
Odds Ratio 162.5 16.98, 1556¹  
Etiologic fraction in pop.(EFp|OR) 
Parameter  Estimate Lower - Upper 95% 
CIs 
Sensitivity 86.21% (69.44, 94.5¹ ) 
Specificity 96.3% (81.72, 99.34¹ ) 
Positive Predictive Value 96.15% (81.11, 99.32¹ ) 
Negative Predictive Value 86.67% (70.32, 94.69¹ ) 
Diagnostic Accuracy 91.07% (80.74, 96.13¹ ) 
Likelihood ratio of a Positive Test 23.28 (3.238 - 167.3) 
Likelihood ratio of a Negative Test 0.1432 (0.0875 - 0.2345) 
Diagnostic Odds 162.5 (16.97 - 1556) 
Cohen's kappa (Unweighted) 0.8219 (0.5615 - 1.082) 
Entropy reduction after a Positive 
Test 
52.95%   
Entropy reduction after a Negative 
Test 
29.98%   
Bias Index -0.05357   
85.68
% 
72.6, 98.75 
Etiologic fraction in exposed(EFe|OR) 99.38
% 
94.11, 99.94 
 
 
 
There is a statistically significant correlation between post prandial pain ad 
mesenteric ischemia. 
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  MESENTERIC 
ISCHEMIA 
  
  (+) (-)  
 (+) 23 2 25 
PERIPHERAL 
VASCULAR DISEASE 
(-) 6 25 31 
  29 27 56 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
26.41 0.000000276 
 
 
 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 92% 73.9, 98.91 
Risk in Unexposed 19.35% 8.818, 36.65 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 4.753 2.296, 9.841¹  
Risk Difference 72.65% 55.14, 90.15°  
Etiologic fraction in 
pop.(EFp) 
62.63% 40, 85.25 
Etiologic fraction in 
exposed(EFe) 
78.96% 56.44, 89.84 
 
     
PVD 
79% (23) 
No PVD 
21% (6) 
PVD 
65 
 
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 43.03 8.943, 334.4¹  
  7.631, 475.3¹  
Odds Ratio 47.92 8.776, 261.6¹  
Etiologic fraction in 
pop.(EFp|OR) 
77.66% 61.56, 93.75 
Etiologic fraction in 
exposed(EFe|OR) 
97.91% 88.61, 99.62 
 
Parameter  Estimate Lower - Upper 95% 
CIs 
Sensitivity 79.31% (61.61, 90.15¹ ) 
Specificity 92.59% (76.63, 97.94¹ ) 
Positive Predictive Value 92% (75.03, 97.78¹ ) 
Negative Predictive Value 80.65% (63.72, 90.81¹ ) 
Diagnostic Accuracy 85.71% (74.26, 92.58¹ ) 
Likelihood ratio of a Positive Test 10.71 (3.93 - 29.17) 
Likelihood ratio of a Negative Test 0.2234 (0.1602 - 0.3117) 
Diagnostic Odds 47.92 (8.775 - 261.7) 
Cohen's kappa (Unweighted) 0.7154 (0.4561 - 0.9746) 
Entropy reduction after a Positive 
Test 
41.37%   
Entropy reduction after a Negative 
Test 
20.12%   
Bias Index -0.07143   
 
 
There is a statistically significant correlation between PVD and mesenteric 
ischemia as evident from the diagram and analysis.  
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Single Table Analysis 
  MESENTERIC ISCHEMIA   
  (+) (-)  
 (+) 1 2 3 
OCP (-) 28 25 53 
  29 27 56 
 
    
Test Value p-
value(
2-tail) 
Yates corrected chi square 0.004048 0.9493 
 
 
 
 
 
 
 
 
 
 
 
 
OCP 
3% (1) 
No OCP 
97% 
OCP Intake  
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Point Estimates  Confidence Limits  
Type Value Lower, Upper Type 
Risk in Exposed 33.33% 5.628, 79.75 Taylor 
series 
Risk in Unexposed 52.83% 39.66, 65.62 Taylor 
series 
Overall Risk 51.79% 39.01, 64.33 Taylor 
series 
Risk Ratio 0.631 0.1248, 3.189¹  Taylor 
series 
Risk Difference -19.5% -74.5, 35.51°  Taylor 
series 
Prevented fraction in 
pop.(pfp) 
1.977% -4.293, 7.536  
Prevented fraction in 
exposed(pfe) 
36.9% -218.9, 87.52  
  
 
     
Parameter  Estimate Lower - Upper 95% CIs 
Sensitivity 3.448% (0.6113, 17.18¹ ) 
Specificity 92.59% (76.63, 97.94¹ ) 
Positive Predictive Value 33.33% (6.149, 79.23¹ ) 
Negative Predictive Value 47.17% (34.38, 60.34¹ ) 
Diagnostic Accuracy 46.43% (34.02, 59.3¹ ) 
Likelihood ratio of a 
Positive Test 
0.4655 (0.00000000000000000000000025
6 - 846500000000000000000000) 
Likelihood ratio of a 
Negative Test 
1.043 (0.9662 - 1.125) 
Diagnostic Odds 0.4464 (0.03813 - 5.227) 
Cohen's kappa 
(Unweighted) 
-0.03832 (-0.1526 - 0.07591) 
Entropy reduction after a 
Positive Test 
5.6%   
Entropy reduction after a 
Negative Test 
0.0965%   
Bias Index -0.4643   
The sample size is too small to illustrate a significant correlation between 
ocp intake and mesenteric ischemia 
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MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 2 8 10 
HYPERTENSION (-) 27 19 46 
  29 27 56 
 
 
 
  
HT 
7% (2) 
NON-HT 
93% (27) 
HYPERTENSION 
    
Test Value p-value(2-tail) 
Yates corrected chi 
square 
3.498 0.06144 
69 
 
 
 
 
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 0.1813 0.02399, 0.8858¹  
  0.01695, 1.049¹  
Odds Ratio 0.1759 0.03356, 0.9223¹  
Prevented fraction in pop(PFpOR) 24.42% -2.698, 40.2 
Prevented fraction in exposed(PFeOR) 82.41% 7.769, 96.64 
 
 
Parameter  Estimate Lower - Upper 95% CIs 
Sensitivity 6.897% (1.912, 21.96¹ ) 
Specificity 70.37% (51.52, 84.15¹ ) 
Positive Predictive Value 20% (5.668, 50.98¹ ) 
 
The study reveals no significant correlation between mesenteric ischemia 
and  hypertension as evident from the statistical analysis. 
  
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 20% 4.589, 52.06 
Risk in Unexposed 58.7% 44.33, 71.73 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 0.3407 0.09636, 1.205¹  
Risk Difference -38.7% -67.28, -10.11°  
Prevented fraction in pop.(pfp) 11.77% 0.318, 20.87 
Prevented fraction in exposed(pfe) 65.93% -20.49, 90.36 
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Negative Predictive Value 41.3% (28.29, 55.66¹ ) 
Diagnostic Accuracy 37.5% (26.01, 50.59¹ ) 
Likelihood ratio of a Positive Test 0.2328 (0.0000003272 - 165600) 
   
 
 
  
Likelihood ratio of a Negative Test 1.323 (1.178 - 1.486) 
Diagnostic Odds 0.1759 (0.03355 - 0.9224) 
Cohen's kappa (Unweighted) -0.2219 (-0.4179 - -0.02595) 
Entropy reduction after a Positive Test 19.21%   
Entropy reduction after a Negative Test 1.456%   
Bias Index -0.3393   
 
 
 
  
CHD 
34% (10) 
No CHD 
66% (19) 
Coronary  Heart Disease 
 MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 10 8 18 
CORONARY HEART DISEASE (-) 19 19 38 
  29 27 56 
71 
 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
0.01046 0.9186 
 
 
 
 
 
 
 
 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 1.245 0.3963, 3.987¹  
  0.352, 4.52¹  
Odds Ratio 1.25 0.4053, 3.855¹  
Etiologic fraction in 
pop.(EFp|OR) 
6.897% -26.62, 40.41 
Etiologic fraction in 
exposed(EFe|OR) 
20% -100, 74.06 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 55.56% 33.7, 75.46 
Risk in Unexposed 50% 34.85, 65.15 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 1.111 0.6597, 1.871¹  
Risk Difference 5.556% -22.37, 33.48°  
Etiologic fraction in 
pop.(EFp) 
3.448% -13.96, 20.85 
Etiologic fraction in 
exposed(EFe) 
10% -51.58, 46.56 
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Parameter  Estimate Lower - Upper 95% CIs 
Sensitivity 34.48% (19.94, 52.66¹ ) 
Specificity 70.37% (51.52, 84.15¹ ) 
Positive Predictive Value 55.56% (33.72, 75.44¹ ) 
Negative Predictive Value 50% (34.85, 65.15¹ ) 
Diagnostic Accuracy 51.79% (39.01, 64.33¹ ) 
Likelihood ratio of a Positive Test 1.164 (0.6277 - 2.158) 
Likelihood ratio of a Negative Test 0.931 (0.8041 - 1.078) 
Diagnostic Odds 1.25 (0.4053 - 3.856) 
Cohen's kappa (Unweighted) 0.04786 (-0.1935 - 0.2893) 
Entropy reduction after a Positive Test 0.5548%   
Entropy reduction after a Negative Test -
0.06379
% 
  
Bias Index -0.1964   
The study reveals no significant correlation between mesenteric ischemia 
and coronary heart disease as evident from the statistical analysis.. 
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 MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 12 12 24 
DIABETES MELLITUS (-) 17 15 32 
  29 27 56 
 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
0.00149 0.9692 
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 50% 31.43, 68.57 
Risk in Unexposed 53.13% 36.45, 69.13 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 0.9412 0.562, 1.576¹  
Risk Difference -3.125% -29.56, 23.31°  
Prevented fraction in pop.(pfp) 2.521% -23.95, 19.67 
Prevented fraction in exposed(pfe) 5.882% -57.63, 43.8 
Diabetes 
41% (12) 
No DM 
59% (17) 
Diabetes Mellitus 
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There is no significant correlation between mesenteric ischemia and 
diabetes mellitus as illustrated. 
  
 Type Value  
 CMLE Odds Ratio* 0.8843  
 Odds Ratio 0.8824 
 Prevented fraction in pop(PFpOR) 5.229%  
 Prevented fraction in 
exposed(PFeOR) 
11.76%  
Parameter  Estimate Lower - Upper 95% 
CIs 
Sensitivity 41.38% (25.51, 59.26¹ ) 
Specificity 55.56% (37.31, 72.41¹ ) 
Positive Predictive Value 50% (31.43, 68.57¹ ) 
Negative Predictive Value 46.88% (30.87, 63.55¹ ) 
Diagnostic Accuracy 48.21% (35.67, 60.99¹ ) 
Likelihood ratio of a Positive Test 0.931 (0.6274 - 1.382) 
Likelihood ratio of a Negative Test 1.055 (0.8469 - 1.315) 
Diagnostic Odds 0.8824 (0.3059 - 2.545) 
Cohen's kappa (Unweighted) -0.03046 (-0.2882 - 0.2273) 
Entropy reduction after a Positive Test -
0.06379% 
  
Entropy reduction after a Negative Test 0.1317%   
Bias Index -0.08929   
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 MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 2 19 21 
CHRONIC ABDOMINAL PAIN (-) 27 8 35 
  29 27 56 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
21.4 0.000003721 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
Risk in Exposed 9.524% 1.446, 30.12 
Risk in Unexposed 77.14% 60.74, 88.17 
Overall Risk 51.79% 39.01, 64.33 
Risk Ratio 0.1235 0.03264, 0.467¹  
Risk Difference -67.62% -86.36, -48.88°  
Prevented fraction in 
pop.(pfp) 
32.87% 17.2, 43.55 
Prevented fraction in 
exposed(pfe) 
87.65% 53.3, 96.74 
 
     
Point Estimates  Confidence Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 0.03391 0.004505, 0.158¹  
  0.003181, 0.1843¹  
Odds Ratio 0.03119 0.005949, 0.1635¹  
Prevented fraction in 
pop(PFpOR) 
68.18% -579.3, 74.04 
Prevented fraction in 
exposed(PFeOR) 
96.88% 83.65, 99.41 
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Parameter  Estimate Lower - Upper 95% CIs 
Sensitivity 6.897% (1.912, 21.96¹ ) 
Specificity 29.63% (15.85, 48.48¹ ) 
Positive Predictive Value 9.524% (2.652, 28.91¹ ) 
Negative Predictive Value 22.86% (12.07, 39.02¹ ) 
Diagnostic Accuracy 17.86% (10, 29.84¹ ) 
Likelihood ratio of a 
Positive Test 
0.098 (0.0000001588 - 60500) 
Likelihood ratio of a 
Negative Test 
3.142 (1.633 - 6.046) 
Diagnostic Odds 0.03119 (0.005948 - 0.1635) 
Cohen's kappa 
(Unweighted) 
-0.6283 (-0.8795 - -0.3771) 
Entropy reduction after a 
Positive Test 
37.8%   
Entropy reduction after a 
Negative Test 
15.5%   
Bias Index -0.1429   
There is a statistically significant correlation between chronic abdominal 
pain and mesenteric ischemia. 
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MESENTERIC ISCHEMIA 
  (+) (-) 
 (+) 12 15 27 
WEIGHT LOSS (-) 17 12 29 
  29 27 56 
 
    
Test Value p-value(2-
tail) 
Yates corrected chi 
square 
0.6292 0.4276 
      
 Point Estimates  Confidence Limits 
 Type Value Lower, Upper 
 Risk in Exposed 44.44% 27.57, 62.7 
 Risk in Unexposed 58.62% 40.71, 74.51 
 Overall Risk 51.79% 39.01, 64.33 
 Risk Ratio 0.7582 0.4504, 1.276¹  
 Risk Difference -14.18% -40.11, 11.76°  
 Prevented fraction in 
pop.(pfp) 
11.66% -13.04, 27.5 
 Prevented fraction in 
exposed(pfe) 
24.18% -27.64, 54.96 
  
Point Estimates  Confidence 
Limits 
Type Value Lower, Upper 
CMLE Odds Ratio* 0.5706 0.1919, 1.66¹  
  0.1715, 1.844¹  
Odds Ratio 0.5647 0.1958, 1.629¹  
Prevented fraction in 
pop(PFpOR) 
24.18% 23.84, 50.15 
Prevented fraction in 
exposed(PFeOR) 
43.53% -62.89, 80.42 
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Parameter  Estimate Lower - Upper 
95% CIs 
Sensitivity 41.38% (25.51, 59.26¹ ) 
Specificity 44.44% (27.59, 62.69¹ ) 
Positive Predictive Value 44.44% (27.59, 62.69¹ ) 
Negative Predictive Value 41.38% (25.51, 59.26¹ ) 
Diagnostic Accuracy 42.86% (30.77, 55.86¹ ) 
Likelihood ratio of a Positive 
Test 
0.7448 (0.5186 - 1.07) 
Likelihood ratio of a Negative 
Test 
1.319 (0.9583 - 1.815) 
Diagnostic Odds 0.5647 (0.1958 - 1.629) 
Cohen's kappa (Unweighted) -0.1414 (-0.4026 - 0.1198) 
Entropy reduction after a 
Positive Test 
0.5548%   
Entropy reduction after a 
Negative Test 
1.43%   
Bias Index -0.03571   
There exists a no statistically significant correlation between mesenteric 
ischemia and weight loss. 
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Out of the total 29 cases which were positive 9 cases had an acute 
presentation while 20 cases were identified while screening for risk factors. 
This chart illustrates the various risk factors prevalent in acute cases and 
cases that were screened. 
These patients were put on anticoagulant therapy with the treatment of the 
underlying disorders and were regularly followed up. This clearly revealed 
a significant reduction in morbidity in these patients thus signifying the 
importance of this study.  
0
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CONCLUSION: 
         This study clearly reveals a substantial association between mesenteric 
ischemia and smoking, postprandial abdominal pain and PVD. 
         Hence it is mandatory to screen symptomatic smokers, patients with 
postprandial angina and patients with PVD for mesenteric vascular occlusion. 
Prophylactic anticoagulant therapy along with treatment of the underlying 
cause goes a long way in improving the lifestyle of these patients as evident 
from the study. 
Our study also revealed stenosis of celiac and renal vasculature in 2 
patients. Hence, apart from mesenteric ischemia, occlusion of other vasculature 
can also be diagnosed at an earlier stage and intervened at the right time to 
prevent future complications.   
       Hence , high index of suspicion is necessary for earlier diagnosis and 
decreasing morbidity and mortality in patients. 
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LIMITATIONS OF THE STUDY: 
   As our sample size is small, a future research involving a larger sample size is 
mandatory to validate the results of this project. 
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S.no Name Age Sex Smoker 
Post 
prandia
l pain 
Weight 
loss 
Pvd 
Ocp 
intake 
 
Hyperten 
sion  
 
 
Coronary 
heart disease 
Chronic 
abd.pain 
Diabetes Ischemia 
Vessel 
(S-
SCREENING; 
A-ACUTE) 
1.  Rangasamy 54 m No No No No No Yes No Yes No No  
2.  Patteswaran 58 m No No No No No No No Yes Yes No COELIAC(S) 
3.  Marappan 62 m No No No No No No No Yes Yes No  
4.  Ramasamy 48 m No No No No No No Yes Yes Yes No 
AORTA & 
RENAL (S) 
5.  Rajaram 58 m No No Yes No No No Yes No Yes No  
6.  Jayaraman 63 m No No No No No No No Yes Yes No  
7.  Natarajan 60 m No No Yes No No No Yes Yes Yes Yes SMA(S) 
8.  Jeevanandan 55 m No No Yes No No Yes No Yes No No  
9.  Velammal 50 f No Yes No No No Yes Yes No No Yes 
AORTA & 
SMA(S) 
10.  Nageshwari 41 f No Yes No No Yes No No No No Yes SMA(S) 
11.  selvamuthukumaran 53 m No Yes No Yes No No No No No Yes SMA(S) 
12.  Uthiramani 54 f No No Yes No No Yes No Yes No No  
13.  Logeswari 37 f No No No No Yes No No Yes No No  
14.  Narayanan 50 m No No Yes No No No Yes Yes No No  
15.  Kalaiyarasan 53 m No No Yes No No Yes No No Yes No  
16.  marudammal 56 f No No No No No No Yes Yes No Yes SMA(A) 
17.  Vijayakumaran 52 m No No No No No No Yes No Yes No  
18.  maran 52 m No No Yes No No No No Yes Yes No  
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19.  narayanamoorthy 48 m No No No No No Yes No Yes No No  
20.  venkateswaran 52 M No No Yes No No Yes No Yes No No COELIAC (S) 
21.  ramakrishnan 50 m No No Yes No No Yes No Yes No No  
22.  Kalaiselvi 42 f No No No No Yes No No Yes No No  
23.  mohammed hanifa 60 M No No Yes No No No Yes Yes No No  
24.  Thiruselvan 50 M No No Yes No No Yes No No Yes No  
25.  Sengottayan 60 m Yes No No No No No Yes No No No  
26.  Arumugam 58 m Yes No Yes No No No No Yes Yes No COELIAC (S) 
27.  Kumaran 42 f Yes No No No No No No Yes No No  
28.  Periyasamy 49 m Yes No Yes No No No Yes Yes No No  
29.  Arumugam 60 m Yes No Yes No No No Yes Yes No No  
30.  Kusalavan 57 m Yes No No No No Yes No No No Yes SMA(A) 
31.  Ramasamy 48 m Yes Yes No No No No No No No Yes SMA(S) 
32.  Arumugam 54 m Yes Yes No Yes No No No No Yes Yes SMA(S) 
33.  Patteswaran 58 m Yes Yes No Yes No No No No Yes Yes SMA(S) 
34.  Saravanan 38 m Yes Yes No No No No No No Yes Yes IMV(A) 
35.  Marappan 62 m Yes Yes No Yes No No Yes No Yes Yes SMA(S) 
36.  Arumugam 50 m Yes No Yes Yes No No Yes No Yes Yes SMA(S) 
37.  balasubramaniam 58 m Yes Yes Yes Yes No No Yes No Yes Yes SMA(S) 
38.  Mohammad 58 m Yes Yes No Yes No No No No Yes Yes SMA(A) 
39.  subramaniyam 55 m Yes Yes Yes Yes No No No No Yes Yes SMA(A) 
40.  senthilkumar 48 m Yes Yes Yes Yes No No No No Yes Yes SMA(A) 
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41.  Venugopal 60 m Yes Yes No Yes No No No No Yes Yes SMA(S) 
42.  Ramanujam 60 m Yes Yes Yes Yes No No Yes No Yes Yes 
AORTA & 
SMA(S) 
43.  Palanisamy 41 m Yes Yes No Yes No No Yes No No Yes SMV(A) 
44.  thirumurugan 50 m Yes Yes Yes Yes No No Yes No No Yes SMV(A) 
45.  Murugeshan 47 m Yes Yes Yes Yes No No No No No Yes AORTA (s)) 
46.  radhakrishnan 50 m Yes Yes No Yes No No No No No Yes 
PORTAL VEIN 
& SMV(S) 
47.  Ramesh 48 m Yes Yes No Yes No No Yes No No Yes 
PORTAL VEIN 
& SMV S) 
48.  Veeramani 50 m Yes Yes Yes Yes No No No No No Yes SMV(S) 
49.  Saleem 49 m Yes Yes No Yes No No No No No Yes SMV(S) 
50.  udhayakumar 45 m Yes Yes No Yes No No No No No Yes SMV(S) 
51.  selvaputhiran 53 m Yes Yes Yes Yes No No No No No Yes 
PORTAL VEIN 
& SMV (S) 
52.  Palanisamy 52 m Yes Yes Yes Yes No No No No No Yes IMA(S) 
53.  poutharaman 51 m Yes Yes Yes Yes No No No No No Yes SMA(S) 
54.  Dhandapani 48 m Yes Yes Yes Yes No No No No No Yes SMV(A) 
55.  Ramadoss 54 m Yes No Yes Yes No No No No Yes No  
56.  syed Ibrahim 57 m Yes No No Yes No No No No Yes No  

